Citicoline 1g 6 Months: Ischemic Stroke Cognition +28%, Motor Recovery +35% RCT
WELLNESS

Citicoline 1g 6 Months: Ischemic Stroke Cognition +28%, Motor Recovery +35% RCT

By Sophie · · Stroke 2026
KO | EN

Citicoline (CDP-choline) 1g/day for 6 months improved cognitive function (MMSE) by 28%, motor recovery (NIHSS) by 35%, daily living independence (Barthel index) by 32%, depression (BDI) by 28%, and quality of life (SF-36) by 35% in 380 ischemic stroke patients, per a 2026 Stroke (AHA) RCT. Recovery matrix validation for the era of 110,000+ annual stroke cases in Korea, with 60%+ experiencing cognitive and motor sequelae.

The study followed acute ischemic stroke patients (within 14 days of onset) over 6 months in a randomized double-blind design. Citicoline 1,000mg/day (oral) + standard rehab vs placebo + standard rehab. Results: MMSE +28% (24 → 26.5), NIHSS -35% (8 → 5.2), Barthel +32% (55 → 73), BDI -28% (18 → 13), SF-36 +35%, MRI gray matter volume +12%, BDNF +25%. Side effects: minimal.

Citicoline — Core Molecule for Phosphatidylcholine Synthesis

What it is:

  • CDP-choline (cytidine diphosphate choline) = citicoline
  • Direct precursor for phosphatidylcholine (PC) synthesis
  • Core phospholipid (50%+) of neuronal membranes
  • 1980s standard stroke treatment in Japan and Europe (Somazina, Ceraxon)

Mechanisms:

  • Provides neuronal membrane PC + choline + cytidine
  • Acetylcholine synthesis ↑ → cognitive function recovery
  • BDNF, NGF, VEGF neurotrophic factor elevation
  • Glutamate excitotoxicity block → neuroprotection
  • Cerebral microcirculation +25% (vasodilation)

Ischemic Stroke — Korea 110,000+ Annually

Korean statistics:

  • 110,000+ annual cases, 4th leading cause of death
  • 80% in 60+, 60%+ have sequelae (motor, cognitive, language)
  • Golden time 3-4.5 hours (tPA thrombolysis)
  • Citicoline matrix is core during 6+ month recovery phase

Recovery stages:

  • Acute (1-14 days): tPA, thrombectomy + neuroprotection
  • Subacute (2-4 weeks): Rehab start + citicoline initiation
  • Chronic recovery (1-6 months): Rehab + matrix accumulation
  • 6+ months evaluation (BDNF, neuroplasticity core)

1g/day — 6-Month Cumulative Critical Dose

Dose matrix:

  • 250-500mg: General cognitive support (prevention, aging)
  • 1,000mg/day: Stroke recovery matrix (current RCT)
  • 2,000mg/day: Acute neuroprotection (IV available)
  • 6+ months cumulative evaluation

Korean market:

  • Pharmaceutical (Somazina, Corin): physician prescription, insurance
  • OTC/supplement: 30,000-80,000 KRW per 30 days
  • Standardized extracts (CDP-choline 90%+) preferred

Matrix — DHA, B12, Lion’s Mane Synergy

Stroke recovery matrix:

  • Citicoline 1g/day (PC synthesis, acetylcholine)
  • DHA 500mg/day (photoreceptor, brain membrane)
  • Vitamin B12 1,000μg/day (homocysteine ↓)
  • Lion’s mane 500mg/day (NGF, neuroplasticity)
  • Standard rehabilitation (essential)

Cautions

Drug interactions:

  • Anticoagulants and thrombolytics: physician evaluation (bleeding risk)
  • SSRI antidepressants: physician evaluation
  • Insufficient pregnancy/lactation data
  • Take with meals (gastric protection)

Side effects:

  • GI discomfort under 5%
  • Headache 3%
  • Allergic reactions rare
  • 6+ months cumulative evaluation, with physician collaboration

Post-Stroke Cognitive Decline — Bidirectional Risk

Cascade:

  • Stroke → gray matter damage → cognitive decline
  • Cognitive decline → reduced rehab motivation → reduced motor recovery
  • Reduced motor activity → reduced social activity → depression ↑
  • Depression ↑ → additional cognitive decline → dementia risk +200%

Citicoline blocks:

  • Neuroplasticity +25% → gray matter recovery
  • Cognitive + motor simultaneous recovery → bidirectional effect
  • Depression -28% → rehab motivation ↑
  • 6+ months cumulative → reduced chronic cognitive sequelae

Global Stroke Recovery Market

Japan: Novartis Somazina pharmaceutical market 500 billion KRW+ Europe: Ferrer Ceraxon standard US: NIH 60+ stroke RCTs cumulative Korea: Post-2025 medical collaboration + supplement market growth

Spring 2026, citicoline 1g/day for 6 months validating ischemic stroke cognition +28%, motor recovery +35%, depression -28% marks not just supplements but a new standard for neuroplasticity recovery matrix. With DHA, B12, lion’s mane matrix, accompanied by standard rehabilitation.